About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 535 record(s)
Req # A-2021-000510
Adverse Drug Reaction (ADR) for QUADRIVALENT INFLUENZA VACCINE. Report number: 000933648.Organization: Health Canada
July 2021
Req # A-2021-000513
Adverse Drug Reaction (ADR) for DIPHTHERIA, TETANUS, AC PERTUSSIS, IPV AND HIB VACCINE. Report number: 000934361.Organization: Health Canada
July 2021
Req # A-2021-000525
Adverse Drug Reaction (ADR) for Lansoprazole. Report number: 000945955.Organization: Health Canada
July 2021
Req # A-2021-000538
Adverse Reaction Reports (AERs) for INFLUENZA VACCINE TRIVALENT. Report numbers: 000932950, 000933263, 000932310, 000932476, 000932398, 000933463, 000930942, 000930953, 000933351, 000929846.Organization: Health Canada
July 2021
Req # A-2021-000542
Adverse Drug Reaction (ADR) for RASBURICASE. Report number: 000926095.Organization: Health Canada
July 2021
Req # A-2021-000546
Adverse Reaction Reports (AERs) for METOLAZONE. Report numbers: 000925059, 000923965, 000927098.Organization: Health Canada
July 2021
Req # A-2021-000547
Adverse Drug Reaction (ADR) for CABAZITAXEL. Report number: 000926931.Organization: Health Canada
July 2021
Req # A-2021-000560
Adverse Drug Reaction (ADR) for CEFIXIME. Report number: 000921850.Organization: Health Canada
July 2021
Req # A-2021-000585
Adverse Drug Reaction (ADR) for CHOLESTYRAMINE. Report number: 000923682.Organization: Health Canada
July 2021
Req # A-2014-000178
All records received during the period July 11, 2014 to October 30, 2014 concerning any of the invitations for comments on Health Canada's proposal to reform nutrition labelling on food packages.Organization: Health Canada
July 2020